Impact of TNF inhibitor medication on working ability in axial spondyloarthritis: an observational national registry-based cohort study.

TNFi interrupts the increase in work disabled days evident during the year before its initiation. However, the overall work disability remains high. Treating patients earlier in the nr-axSpA phase, regardless of sex, appears important in maintaining the ability to work.